NO983992L - Serinprotease inhibitorer - Google Patents
Serinprotease inhibitorerInfo
- Publication number
- NO983992L NO983992L NO983992A NO983992A NO983992L NO 983992 L NO983992 L NO 983992L NO 983992 A NO983992 A NO 983992A NO 983992 A NO983992 A NO 983992A NO 983992 L NO983992 L NO 983992L
- Authority
- NO
- Norway
- Prior art keywords
- protease inhibitors
- serine protease
- prodrug
- treat
- compounds
- Prior art date
Links
- 239000003001 serine protease inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200545 | 1996-03-01 | ||
| PCT/EP1997/000939 WO1997031939A1 (en) | 1996-03-01 | 1997-02-26 | Serine protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983992D0 NO983992D0 (no) | 1998-08-31 |
| NO983992L true NO983992L (no) | 1998-10-30 |
Family
ID=8223738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983992A NO983992L (no) | 1996-03-01 | 1998-08-31 | Serinprotease inhibitorer |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6218365B1 (de) |
| EP (1) | EP1012164B1 (de) |
| JP (1) | JP2000506838A (de) |
| KR (1) | KR19990087416A (de) |
| CN (1) | CN1212705A (de) |
| AR (1) | AR006311A1 (de) |
| AT (1) | ATE277074T1 (de) |
| AU (1) | AU715765B2 (de) |
| BR (1) | BR9707812A (de) |
| CA (1) | CA2246722A1 (de) |
| CZ (1) | CZ277998A3 (de) |
| DE (1) | DE69730871D1 (de) |
| HU (1) | HUP9901503A3 (de) |
| ID (2) | ID16104A (de) |
| IL (1) | IL120311A (de) |
| NO (1) | NO983992L (de) |
| NZ (1) | NZ331486A (de) |
| PL (1) | PL328665A1 (de) |
| TR (1) | TR199801705T2 (de) |
| TW (1) | TW523513B (de) |
| WO (1) | WO1997031939A1 (de) |
| ZA (1) | ZA971733B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001525823A (ja) | 1997-05-15 | 2001-12-11 | イーライ・リリー・アンド・カンパニー | 抗血栓化合物 |
| US6344450B1 (en) * | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| CA2370267A1 (en) | 1999-04-09 | 2000-10-19 | Basf Aktiengesellschaft | Prodrugs of thrombin inhibitors |
| WO2002006280A2 (en) * | 2000-07-13 | 2002-01-24 | Millennium Pharamaceuticals, Inc. | INHIBITORS OF FACTOR Xa |
| HUP0304058A2 (hu) | 2001-01-30 | 2004-04-28 | Bristol-Myers Squibb Company | Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
| US6716869B2 (en) * | 2001-12-17 | 2004-04-06 | Pharmacia Corporation | Protease inhibitors of the coagulation cascade isolated from Dysidea sponges |
| CA2477391A1 (en) * | 2002-03-01 | 2003-09-12 | Denis Schrier | Method of treating osteoarthritis |
| US7439226B2 (en) * | 2003-09-30 | 2008-10-21 | The United States Of America As Represented By The Department Of Health And Human Services | Serine protease inhibitors |
| JP2008521853A (ja) * | 2004-12-02 | 2008-06-26 | プロビオドルグ エージー | 神経疾患治療用の新規化合物 |
| RU2419625C2 (ru) | 2006-05-23 | 2011-05-27 | Айрм Ллк | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы |
| US7951823B2 (en) | 2006-05-23 | 2011-05-31 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| EP2117541A1 (de) * | 2007-02-09 | 2009-11-18 | Irm Llc | Verbindungen und zusammensetzungen als kanalaktivierende protease-hemmer |
| KR20090108131A (ko) | 2007-02-09 | 2009-10-14 | 아이알엠 엘엘씨 | 채널 활성화 프로테아제 억제제로서의 화합물 및 조성물 |
| EP4257191A3 (de) | 2016-06-21 | 2023-11-22 | Orion Ophthalmology LLC | Heterocyclische prolinamidderivate |
| WO2017222914A1 (en) | 2016-06-21 | 2017-12-28 | Inception 4, Inc. | Carbocyclic prolinamide derivatives |
| DE102020103516B4 (de) | 2020-02-11 | 2023-12-07 | Universität Zu Lübeck | Antivirale Wirkstoffe mit breiter Aktivität |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| AU2021286560A1 (en) * | 2020-06-09 | 2023-02-02 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| IL298324A (en) | 2020-06-10 | 2023-01-01 | Aligos Therapeutics Inc | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
| CA3224494A1 (en) | 2021-07-09 | 2023-01-12 | Koen Vandyck | Anti-viral compounds |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672582A (en) * | 1993-04-30 | 1997-09-30 | Merck & Co., Inc. | Thrombin inhibitors |
| WO1994025051A1 (en) * | 1993-04-30 | 1994-11-10 | Merck & Co., Inc. | Thrombin inhibitors |
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| JPH10503176A (ja) * | 1994-06-17 | 1998-03-24 | コーバス インターナショナル， インコーポレイテッド | 酵素インヒビターとしての３−アミノ−２−オキソ−１−ピペリジン酢酸誘導体 |
| JPH0820597A (ja) * | 1994-07-07 | 1996-01-23 | Meiji Seika Kaisha Ltd | トロンビン阻害作用を有する複素環カルボニル化合物 |
| JPH11508535A (ja) * | 1994-12-22 | 1999-07-27 | バイオケム ファーマ インコーポレイテッド | 低分子量２環式トロンビン阻害剤 |
| AU719216B2 (en) * | 1996-02-13 | 2000-05-04 | Akzo Nobel N.V. | Serine protease inhibitors |
-
1997
- 1997-02-25 TW TW086102260A patent/TW523513B/zh active
- 1997-02-25 IL IL12031197A patent/IL120311A/en not_active IP Right Cessation
- 1997-02-26 CZ CZ982779A patent/CZ277998A3/cs unknown
- 1997-02-26 WO PCT/EP1997/000939 patent/WO1997031939A1/en not_active Ceased
- 1997-02-26 DE DE69730871T patent/DE69730871D1/de not_active Expired - Lifetime
- 1997-02-26 AU AU17956/97A patent/AU715765B2/en not_active Ceased
- 1997-02-26 EP EP97903384A patent/EP1012164B1/de not_active Expired - Lifetime
- 1997-02-26 US US09/142,068 patent/US6218365B1/en not_active Expired - Fee Related
- 1997-02-26 PL PL97328665A patent/PL328665A1/xx unknown
- 1997-02-26 CN CN97192688A patent/CN1212705A/zh active Pending
- 1997-02-26 BR BR9707812A patent/BR9707812A/pt unknown
- 1997-02-26 KR KR1019980706834A patent/KR19990087416A/ko not_active Ceased
- 1997-02-26 NZ NZ331486A patent/NZ331486A/xx unknown
- 1997-02-26 CA CA002246722A patent/CA2246722A1/en not_active Abandoned
- 1997-02-26 TR TR1998/01705T patent/TR199801705T2/xx unknown
- 1997-02-26 HU HU9901503A patent/HUP9901503A3/hu unknown
- 1997-02-26 JP JP9530601A patent/JP2000506838A/ja not_active Withdrawn
- 1997-02-26 AT AT97903384T patent/ATE277074T1/de not_active IP Right Cessation
- 1997-02-27 ZA ZA9701733A patent/ZA971733B/xx unknown
- 1997-03-03 ID IDP970633A patent/ID16104A/id unknown
- 1997-03-03 AR ARP970100834A patent/AR006311A1/es unknown
- 1997-03-03 ID IDP970634A patent/ID16105A/id unknown
-
1998
- 1998-08-31 NO NO983992A patent/NO983992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU715765B2 (en) | 2000-02-10 |
| ATE277074T1 (de) | 2004-10-15 |
| WO1997031939A1 (en) | 1997-09-04 |
| NO983992D0 (no) | 1998-08-31 |
| IL120311A0 (en) | 1997-06-10 |
| ZA971733B (en) | 1997-09-10 |
| BR9707812A (pt) | 1999-07-27 |
| HUP9901503A2 (hu) | 1999-08-30 |
| NZ331486A (en) | 1999-07-29 |
| JP2000506838A (ja) | 2000-06-06 |
| CA2246722A1 (en) | 1997-09-04 |
| ID16105A (id) | 1997-09-04 |
| HUP9901503A3 (en) | 2001-10-29 |
| TR199801705T2 (xx) | 1998-12-21 |
| TW523513B (en) | 2003-03-11 |
| CN1212705A (zh) | 1999-03-31 |
| CZ277998A3 (cs) | 1999-02-17 |
| US6218365B1 (en) | 2001-04-17 |
| AU1795697A (en) | 1997-09-16 |
| AR006311A1 (es) | 1999-08-25 |
| KR19990087416A (ko) | 1999-12-27 |
| PL328665A1 (en) | 1999-02-15 |
| ID16104A (id) | 1997-09-04 |
| DE69730871D1 (de) | 2004-10-28 |
| EP1012164A1 (de) | 2000-06-28 |
| EP1012164B1 (de) | 2004-09-22 |
| IL120311A (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983991L (no) | Serin-protease-inhibitorer | |
| NO983688L (no) | Serin-protease-inhibitorer | |
| NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
| BR0115861A (pt) | Composto, derivado farmaceuticamente aceitável de um composto, formulação farmacêutica, uso de um composto, métodos de tratamento de uma condição onde a inibição da trombina é requerida e de uma condição onde a terapia anticoagulante é indicada, e, processo para a preparação de um composto | |
| FI942423A0 (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
| ID18143A (id) | Penghambat metaloprotease amina siklik tersubstitusi | |
| NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| WO2002057252A3 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| TR200101120T2 (tr) | Serin proteaz inhibitörü | |
| BR0011130A (pt) | Inibidores de metaloproteases | |
| TR200002904T2 (tr) | Amidin bileşikleri | |
| MY110104A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| FI962022A0 (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| TR199801705T2 (xx) | Serin proteaz inhibit�rleri. | |
| EA200100804A1 (ru) | Сульфоароматические производные гидроксамовой кислоты как ингибиторы металлопротеаз | |
| NO20055565L (no) | Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO) | |
| AU4888401A (en) | Sulfonamide derivative as a matrix metalloproteinase inhibitor | |
| NO20052487L (no) | 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater. | |
| GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| FI962021A0 (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
| DE69819539D1 (de) | Antithrombotische mittel | |
| BR0113212A (pt) | Composto, formulação farmacêutica, uso de um composto ou de um seu derivado farmaceuticamente aceitável, métodos de tratamento de uma condição em que a inibição da trombina é requerida, e de uma condição em que a terapia anticoagulante é indicada, e, processo para a preparação de um composto | |
| WO2002004423A8 (en) | Thrombin inhibitors comprising an aminoisoquinoline group |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |